Daclizumab improves control of chronic persistent asthma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1437, 2004-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mometasone furoate dry-powder inhaler for the control of persistent asthma

By D'Urzo Anthony

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2871-2884

Informa Healthcare

Access to resources Recommend Favorite

Fluticasone propionate more effective maintenance in persistent asthma

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Montelukast: A Review of its Therapeutic Potential in Persistent Asthma

By Jarvis B. Markham A.

Drugs, Vol. 59, Iss. 4, 2000-04 ,pp. : 891-928

Adis International

Access to resources Recommend Favorite

Better advantage with fluticasone propionate in persistent asthma

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 291, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Mometasone matches fluticasone propionate in persistent asthma

Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite